Search results for: 'research area pi3k akt signaling gsk'
-
A8685 Wnt-C592 CitationTarget: PORCNSummary: PORCN inhibitor,highly potent and selective
-
A3887 Trametinib DMSO solvate1 CitationTarget: MEKSummary: Allosteric MEK1/MEK2 kinase inhibitor
-
A3413 FH535Summary: Wnt/B-catenin inhibitor
-
A8254 SB 2035809 CitationTarget: p38|PKBSummary: P38 MAP kinase inhibitor
-
A8499 PF-04691502Target: Akt|PI3K|mTORSummary: PI3K/mTOR (FRAP) inhibitor
-
A8217 ICG 0011 CitationSummary: Wnt/β-catenin pathway inhibitor
-
A1720 Duvelisib (IPI-145, INK1197)Target: PI3KSummary: PI3K-δ/PI3K-γ inhibitor
-
A8324 LDN-193189Target: BMP and Other Activin ReceptorsSummary: ALK inhibitor,potent and selective
-
A8651 LY2940680Target: Smoothened receptorSummary: Hedgehog/SMO antagonist,inhibits Hh signaling
-
A3799 SB-505124 hydrochlorideTarget: ALKSummary: ALK5/ALK4/ALK7 inhibitor in TGF-β/activin signalling,selective